Special clinical interest
A/Prof Brungs completed a medical science degree at the University of NSW in 2002, and his medical degree (MBBS) from the University of Sydney in 2006. While undertaking specialist training he also completed a Masters in Medicine (Clinical Epidemiology) at USyd in 2013. Most recently he has completed a PhD in Molecular Biology as the CONCERT translational cancer centre Clinical Fellow at IHMRI. His PhD research investigated novel personalised therapeutic approaches to treat gastrointestinal cancer, which has led to the development of a robust protocol for the cryopreservation of blood samples for circulating tumour cell (CTC) analysis.
He has been the primary investigator on a range of large phase III clinical trials in lung, genitourinary cancer, as well as phase I clinical trials. He also has a strong background in Clinical Epidemiology, and is the lead author on a number of meta-analyses and analysis of large linked data sets in cancer. He currently divides his time between clinical work and the University of Wollongong working in a translational cancer laboratory.
Research, Awards and Teaching Interests
With his strong interest in research A/Prof Brungs is also a cancer researcher, and a Principle Research Fellow at the Illawarra Health and Medical Research Institute (IHMRI) in the Graduate Medical School at the University of Wollongong.He is also an honorary clinical research fellow at Illawarra Health and Medical Research Institute (IHMRI).
Medical Oncology Group of Australia (MOGA), American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), Australian Gastrointestinal Trials Group (AGITG), Cooperative Trials Group for Neuro-Oncology (COGNO), Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
